LUXEMBOURG: Eurofins Scientific (EUFI.PA), a global leader in bioanalytical testing, has announced the successful acquisition of Ascend Clinical, LLC, the premier independent kidney dialysis laboratory in the United States.

Ascend Clinical, known for its cutting-edge laboratory in Sunnyvale, California, and a dedicated team of 170 professionals, has been at the forefront of providing comprehensive testing services to dialysis centers and hospitals nationwide.

This acquisition marks a pivotal moment for Eurofins, enhancing its portfolio with Ascend’s specialized chemistry, hematology, microbiology, and virology testing services. Moreover, Ascend’s expertise in water and dialysate testing is expected to significantly improve safety standards for dialysis patients and support regulatory compliance.

The synergy between Ascend’s core competencies and Eurofins’ extensive range of pre- and post-transplant services promises to deliver superior and more expansive service offerings to their clientele. The move also solidifies Eurofins’ commitment to transplant testing and renal care, extending its clinical reach.

Ascend Clinical stands to benefit from Eurofins’ vast laboratory network and established industry connections. Patti Hunsader, Ascend’s COO, is set to lead as President, ensuring continuity in leadership and vision. The existing management team will continue to propel the company’s growth trajectory within Eurofins’ clinical diagnostics division in the U.S.

The integration of Ascend’s specialized services with Eurofins’ technological prowess and national coverage is poised to set a new benchmark in patient care across the country.

Comment from Dr. Gilles Martin, Eurofins CEO: “This transaction further extends our efforts to provide best in class testing care to patients in the renal and transplantation fields. We look forward to providing Ascend’s clients with access to the capabilities of the Eurofins network, and to support Ascend in strengthening and growing the important services they provide to patients.”

Comment from Patti Hunsader, Ascend COO: “We are excited to join forces with the Eurofins network. This partnership creates exciting opportunities to leverage our combined expertise and resources to positively impact the lives of the patients we serve.”

Eurofins Scientific to acquire operations of SGS Crop Science in 14 countries